The landscape of diabetic treatment is rapidly progressing, and cellular treatment are emerging as a remarkably exciting area of research. While existing protocols often focus on regulating blood sugar levels and addressing secondary issues, cell-based intervention holds the potential to target the underlying causes of Type 2 diabetic conditions. I